Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Quality of Life Changes >10 Years After Postoperative Radiation Therapy After Radical Prostatectomy for Prostate Cancer.

Leufgens F, Berneking V, Vögeli TA, Kirschner-Hermanns R, Eble MJ, Pinkawa M.

Int J Radiat Oncol Biol Phys. 2019 Jun 12. pii: S0360-3016(19)30829-6. doi: 10.1016/j.ijrobp.2019.06.004. [Epub ahead of print]

PMID:
31201895
2.
3.

Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer - a prospective analysis.

Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Holy R, Krenkel B, Eble MJ.

Radiother Oncol. 2008 Jul;88(1):135-9. Epub 2007 Nov 19.

PMID:
18022263
4.

[Quality of life after robotic prostatectomy: Impact of BMI and age on urinary incontinence].

Limani K, Albisinni S, Aoun F, Le Dinh D, Biaou I, Hawaux E, Peltier A, van Velthoven R.

Prog Urol. 2017 Mar;27(4):244-252. doi: 10.1016/j.purol.2016.10.008. Epub 2016 Dec 6. French.

PMID:
27939417
5.

Quality of Life After Radiation Therapy for Prostate Cancer With a Hydrogel Spacer: 5-Year Results.

Pinkawa M, Berneking V, Schlenter M, Krenkel B, Eble MJ.

Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):374-377. doi: 10.1016/j.ijrobp.2017.05.035. Epub 2017 May 31.

6.

Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost.

Pinkawa M, Piroth MD, Holy R, Klotz J, Djukic V, Corral NE, Caffaro M, Winz OH, Krohn T, Mottaghy FM, Eble MJ.

Radiat Oncol. 2012 Jan 30;7:14. doi: 10.1186/1748-717X-7-14.

7.

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.

Wilkins A, Mossop H, Syndikus I, Khoo V, Bloomfield D, Parker C, Logue J, Scrase C, Patterson H, Birtle A, Staffurth J, Malik Z, Panades M, Eswar C, Graham J, Russell M, Kirkbride P, O'Sullivan JM, Gao A, Cruickshank C, Griffin C, Dearnaley D, Hall E.

Lancet Oncol. 2015 Dec;16(16):1605-16. doi: 10.1016/S1470-2045(15)00280-6. Epub 2015 Oct 28.

8.

Life after radical prostatectomy: a longitudinal study.

Litwin MS, Melmed GY, Nakazon T.

J Urol. 2001 Aug;166(2):587-92.

PMID:
11458073
9.

The impact of prostate size on urinary quality of life indexes following laparoscopic radical prostatectomy.

Levinson AW, Bagga HS, Pavlovich CP, Mettee LZ, Ward NT, Link RE, Su LM.

J Urol. 2008 May;179(5):1818-22. doi: 10.1016/j.juro.2008.01.050. Epub 2008 Mar 18.

PMID:
18353375
10.

Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy.

Herlemann A, Cowan JE, Carroll PR, Cooperberg MR.

Eur Urol. 2018 Feb;73(2):215-223. doi: 10.1016/j.eururo.2017.04.027. Epub 2017 May 9.

PMID:
28499617
11.

Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.

Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE, Tyson MD, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF.

JAMA. 2017 Mar 21;317(11):1126-1140. doi: 10.1001/jama.2017.1704. Erratum in: JAMA. 2017 May 23;317(20):2134.

12.

Prospective assessment of time-dependent changes in quality of life of Japanese patients with prostate cancer following robot-assisted radical prostatectomy.

Miyake H, Miyazaki A, Furukawa J, Hinata N, Fujisawa M.

J Robot Surg. 2016 Sep;10(3):201-7. doi: 10.1007/s11701-016-0565-0. Epub 2016 Feb 17.

PMID:
26885662
13.

Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer.

Zelefsky MJ, Poon BY, Eastham J, Vickers A, Pei X, Scardino PT.

Radiother Oncol. 2016 Jan;118(1):85-91. doi: 10.1016/j.radonc.2015.11.035. Epub 2016 Jan 9.

14.

Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparison.

Pinkawa M, Piroth MD, Holy R, Fischedick K, Klotz J, Székely-Orbán D, Eble MJ.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):23-8. doi: 10.1016/j.ijrobp.2010.05.054. Epub 2010 Sep 9.

PMID:
20832182
15.

Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer.

Bhattasali O, Chen LN, Woo J, Park JW, Kim JS, Moures R, Yung T, Lei S, Collins BT, Kowalczyk K, Suy S, Dritschilo A, Lynch JH, Collins SP.

Radiat Oncol. 2014 Feb 11;9:52. doi: 10.1186/1748-717X-9-52.

16.

Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience.

Mercado C, Kress MA, Cyr RA, Chen LN, Yung TM, Bullock EG, Lei S, Collins BT, Satinsky AN, Harter KW, Suy S, Dritschilo A, Lynch JH, Collins SP.

Front Oncol. 2016 May 6;6:114. doi: 10.3389/fonc.2016.00114. eCollection 2016.

17.

An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.

Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA.

J Urol. 2007 Jun;177(6):2151-6; discussion 2156. Erratum in: J Urol. 2007 Sep;178(3 Pt 1):1125.

PMID:
17509305
18.

Age and baseline quality of life at radical prostatectomy--who has the most to lose?

Brajtbord JS, Punnen S, Cowan JE, Welty CJ, Carroll PR.

J Urol. 2014 Aug;192(2):396-401. doi: 10.1016/j.juro.2014.02.045. Epub 2014 Feb 25.

PMID:
24582539
19.

Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study.

Pinkawa M, Holy R, Piroth MD, Fischedick K, Schaar S, Székely-Orbán D, Eble MJ.

Radiat Oncol. 2010 Apr 8;5:27. doi: 10.1186/1748-717X-5-27.

20.

Bother problems in prostate cancer patients after curative treatment.

Stensvold A, Dahl AA, Brennhovd B, Småstuen MC, Fosså SD, Lilleby W, Steinsvik A, Axcrona K, Smeland S.

Urol Oncol. 2013 Oct;31(7):1067-78. doi: 10.1016/j.urolonc.2011.12.020. Epub 2012 Feb 16.

PMID:
22341412

Supplemental Content

Support Center